Business Daily Media

The Times Real Estate

.

Cardinal Health acquires smart prescription platform ScalaMed


Cardinal Health (NYSE:CAH) announced the acquisition of ScalaMed, a HIPAA-compliant, smart platform that transfers prescriptions directly to patients via a secure mobile app. The acquisition transfers ScalaMed’s technology and assets to Outcomes™, a Cardinal Health company.

ScalaMed pivots prescription management from provider to patient, allowing patients to send prescriptions written by their provider directly to any pharmacy for the first fill. The platform offers patients greater flexibility, easier access, and price comparison to select the pharmacy of their choice.

For providers, the platform eliminates the administrative work of transferring prescriptions, saving the average clinician 40 hours per year, and helps improve health outcomes with improved adherence, and increased patient satisfaction. Scalamed’s technology will be offered through the Cardinal Health nationwide pharmacy network, creating unprecedented opportunities for digital connectivity to millions of patients.

“As healthcare continues to evolve toward patient preferences, the acquisition of ScalaMed allows us to center our connected ecosystem around the patient from the outset of their treatment journey - from the doctor’s office to the pharmacy to home,” said Brent Stutz, SVP/GM of Outcomes™, a Cardinal Health Company. “Using ScalaMed’s technology, we can better support patients at every step along their treatment journey through unified communication and more informed insights that will help remove access and adherence barriers.”

Built by physicians and pharmacists with first-hand knowledge of how prescriptions are often mismanaged in the current healthcare system, ScalaMed worked to develop a digital solution that empowered patients and personalized their care, taking into account the real-world challenges of daily life that often lead to medication nonadherence.

“The process of digitizing prescriptions removes the patient from the equation and overlooks the complexity of the real-life adherence challenges patients face – forgetting medication on vacation, not having a pharmacy with convenient hours nearby, the variables are endless,” said Dr. Tal Rapke, MD CEO and Founder of ScalaMed. “We’re excited to partner with a leader in pharmacy like Cardinal Health, so that together, we can offer a solution that is both smart and patient-centric. With the scale and innovation Cardinal Health offers, we can revolutionize how prescriptions are filled and help solve the massive, costly challenge of medication nonadherence.”

Businesses losing an average of $493k from data integrity flaws

Managing data responsibly and effectively for the AI age can give organisations a strong competitive advantage, but many are failing to harness th...

AI shopping disruptor Zyft raises $7.5M to lead the next gen of retail tech

Zyft appoints new CEO, Richard Stevens, to lead the latest Waller Group success story, valued at $30 million SYDNEY, 28 April 2025: Zyft, the lea...

Little known law offers savvy Kiwis the opportunity to supercharge their retirement savings

A little-known legal amendment is being leveraged by savvy New Zealanders and expat Brits to supercharge their retirement savings. Not many peop...

Cutting edge AI technology designed for doctors to reduce patient wait times launched in NZ

New Zealand specialist doctors now have access to Artificial Intelligence technology to help reduce patient wait times and experts say it could be...

Launchd Takes Off: Former AFL Stars Lead Tech-Powered Platform Set to Disrupt Talent and Influencer Marketing

Backed by Institutional Capital, Launchd Combines Five Leading Agencies and Smart Technology to Deliver Measurable Results Influencer marketing i...

Meet the Australian fintech unlocking rewards for small businesses

Small businesses make up 98 per cent of all businesses in Australia, yet they continue to bear the brunt of economic uncertainty. According to Credi...

Sell by LayBy